Sector News

Chemtrade to buy Canexus for $675 million

December 19, 2016
Energy & Chemical Value Chain

Chemtrade Logistics Income Fund (Toronto, Ontario, Canada) and Canexus (Calgary, Alberta, Canada) have reached an agreement, under which Chemtrade will acquire Canexus for C$1.65/share in cash.

The transaction is to be completed by way of a plan of arrangement under Alberta’s Business Corporations Act. The deal values Canexus at about C$900 million (US$675 million). The companies confirmed earlier this week that they were discussing a deal at C$1.65/share.

The acquisition price is a 33% premium to Canexus’s closing price of C$1.24/share on 13 September, the last trading day before Chemtrade announced its initial C$1.45/share bid for Canexus. That bid was rejected and Chemtrade launched a hostile C$1.50/share bid for Canexus in October. Chemtrade expects the deal to close by the end of April 2017, subject to regulatory approvals and customary closing conditions.

Shareholders accounting for about 20% of Canexus’s equity, including all Canexus directors and officers, and the company’s largest shareholder Stirling Global Value Fund, have entered into binding agreements to vote their shares in favor of the agreeement, Chemtrade says. Canexus’s shareholders will consider the agreement at a meeting to be held in early February 2017. The deal will require approval from at least 66.67% of shareholders at that meeting.

Chemtrade says it has sufficient capital to fund the acquisition from available cash resources and from firm, committed financing. The company is entitled to a termination fee of C$25 million if Canexus agrees to a “superior proposal” from another company, Chemtrade says. Chemtrade also has the right to match any unsolicited, superior proposal.

Canexus produces sodium chlorate and chlor-alkali products mainly for the pulp and paper, and water tratment industries. The company has production at four plants in Canada and two in Brazil. Chemtrade is a maker of inorganic chemicals, including sulfuric acid, coagulants for water treatment, and sodium chlorate. The proposed deal “will strengthen and expand Chemtrade’s existing platform while further diversifying our North American operations and allowing us to enter attractive South American markets,” says Chemtrade CEO Mark Davis.

Canexus says its board has “unanimously determined that the arrangement is in the best interests of Canexus.” CIBC Capital Markets and The Valence Group are advising Canexus.

By Ian Young

Source: Chemical Week

comments closed

Related News

February 25, 2024

Antwerp Declaration for a European Industrial Deal: industry leaders call for 10 urgent actions to restore competitiveness and keep good jobs in Europe

Energy & Chemical Value Chain

During a European Industry Summit held on the site of BASF in Antwerp, leaders from basic industry sectors, representing 7.8 million workers in Europe, joined forces with European trade unions and European leaders to address pressing concerns regarding Europe’s industrial landscape.

February 25, 2024

Blue hydrogen could contribute 50% more to global warming than fossil fuels

Energy & Chemical Value Chain

The use of blue or low-carbon hydrogen, made from natural gas with carbon capture and storage (CCS), could increase near-term global warming by 50% compared with burning fossil fuels directly for energy if emissions are not properly managed, according to a new study by NGO the US Environmental Defense Fund (EDF) and the University of Arizona.

February 25, 2024

EU approves €6.9 Billion state aid for 33 hydrogen projects

Energy & Chemical Value Chain

In a move to improve the supply of renewable hydrogen and thus reduce dependence on natural gas and contribute to achieving the objectives of the European Green Deal and the REPowerEU plan, the EU Commission has approved a third Important project of common European interest (IPCEI) to support hydrogen infrastructure.

How can we help you?

We're easy to reach